Home > Back to Publisher > Report Information

Indian Biopharmaceuticals

Cygnus Business Consulting and Research
January 1, 2008
211 Pages - SKU: CYG1692624

Abstract Table of Contents Search inside this report Related Reports

Countries covered: India

India is counted among the top 12 global biotech hotspots and is the 3rd largest in Asia Pacific (in terms of number of biotech companies). The global biotech industry size is currently USD73.12 billion, whereas the Indian biotech industry just crossed the USD2 billion (INR 85.41 billion) mark in 2006-07. Bio Pharma remained the largest contributor with a value contribution of INR59.73 billion accounting for a 69.73% contribution.Biopharmaceuticals are complex macromolecules (Large molecules) created through the genetic manipulation of living organisms using gene cloning, recombinant DNA (gene splicing), or cell fusion technologies. The total Biopharma industry, comprising of vaccines, therapeutics, other products like statins, and diagnostics registered 26.9% growth in 2006-07 and the segment still is the single largest contributor to the Indian biotech industry.

The report aims at recent trend in biopharma, global market and its trend, estimates of the future market, growth drivers, critical success factors, issues and challenges, core technologies in biopharma,regulatory environment, profiles of major players and their products offering in biopharma.

The report on biopharma provides a segment analysis with reference to vaccines,diagnostics,therapeutics.At the end report provides future outlook of biopharma industry.

EXECUTIVE SUMMARY HIGHLIGHTS
1. INDUSTRY OVERVIEW: 1.1 The Industry; 1.2 Introduction to Biopharma; 1.3 Biopharma Market Size; 1.4 Biopharma Industry Segments; 1.5 Contribution of Biopharma sector to domestic & exports sales of Biotechnology
2. SEGMENT ANALYSIS - BIOPHARMA: 2.1 Segment Analysis: Vaccines; 2.2 Segment Analysis: Diagnostics; 2.3 Segment Analysis: Therapeutics
3. GROWTH DRIVERS: 3.1 Growing population and improving incomes; 3.2 Emerging lifestyle diseases; 3.3 Increasing Investment in Infrastructure and R&D; 3.5 Increasing Outsourcing Opportunities; 3.6 Emerging Contract Research Market
4. ISSUES & CHALLENGES: 4.1 Increasing Productivity & Profitability; 4.2 Lack of Skilled manpower in the area of bio-pharma; 4.3 Daunting regulatory system; 4.4 A Confusing Patent Law for India; 4.5 Ethical Issues; 4.6 FDA Regulations; 4.7. Environmental Factors; 4.8 Bioequivalence issue in Bio-generics; 4.9 Comparative Low R&D Expenditures Result in Price Wars; 4.10 Sub-Critical Resource Allocation by Public Companies; 4.11 High Duties on Imported Products Restrains Volume Growth; 4.12 Having Tailor-Made Drugs Could Result in Loss of Potential Revenues; 4.13 Small Biotech Start Ups Find Marketing of Products Difficult; 4.14 Access to capital; 4.15 Reducing Time to Market
5. CORE TECHNOLOGIES IN BIOPHARMA: 5.1 Antisense Technology; 5.2 Immobilization of enzymes and cells; 5.3 Cell culture; 5.4 Monoclonal Antibodies; 5.5 Protein engineering; 5.6 Biosensors; 5.7 Microarrays; 5.8 Enzyme engineering and Technology
: 6.1. Serum Institute of India Ltd.; 6.2 Biocon Ltd.; 6.3 Panacea Biotech Ltd; 6.4 Venkateshwara Hatcheries Private Ltd.; 6.5 Novo Nordisk 6.6 Aventis Pharma Limited; 6.7 Indian Immunologicals Ltd.; 6.8 Glaxo SmithKline Pharmaceuticals Ltd.; 6.9 Shantha Biotechnics; 6.10 Bharat Serums and Vaccines Ltd
7. REGULATORY ENVIRONMENT IN BIOPHARMA: 7.1 Government of India Policy on Biotechnology; 7.2 Existing Regulatory Framework; 7.3 IPR Issues in Biotechnology; 7.4 Funding Agencies in Biotech Research; 7.5 Budgetary Allocation; 7.6 Venture Capital Funding; 7.7 Foreign Direct Investments; 7.8 National Biotech Development Strategy - 2005; 7.9 Sectoral Road Map from DBT on Biopharma; 7.10 Biopiracy; 7.11 Biosafety
8. CRITICAL SUCCESS FACTORS: 8.1 Human Resources; 8.2 New Product Development; 8.3 Networking: Strategic Alliances & Partnering Activities; 8.4 Co-development; 8.5 Economies in R&D; 8.5 Research & Development; 8.6 Therapeutic Segment Coverage; 8.7 Meeting the Global Demand; 8.8 World-class Practices
9. EMERGING TRENDS: 9.1 Big Pharmaceutical Companies Are Scouting For Biopharma Partners; 9.2 Increasing Demand for Biogenerics; 9.3 Companies Specialising In Specific Therapeutic or Disease Areas; 9.4 R&D Spend On the Rise; 9.5 Global Biotech R&D Productivity on the Rise; 9.6 Increasing Outsourcing by Pharmaceutical Companies; 9.7 Immunogenicity
10. OPPORTUNITIES IN INDIA: 10.1 Increasing Pharma R&D opportunities in India; 10.2 Opportunities in Clinical Research; 10.3 Increasing Opportunities in Contract Manufacturing
11. OUTLOOK BIBLIOGRAPHY GLOSSARY ANNEXURE I
List of Tables: Table 1 Major Players in Indian Bio Pharma Sector; Table 1.1: Export Vs Domestic Business in 2006-07; Table 1.2: Segmental Revenue in Biopharma Sector, 2006-07; Table 2.1: Product Segments in the Vaccine Market; Table 2.2: Top Ten Players in Indian Vaccine Segment, 2006-07; Table 2.3: Major Vaccines; Table 2.4: Major Players in the Indian Diagnostic Industry, 2006-07; Table 2.5: Major Diagnostics; Table 2.6: Major segments in the Antibiotics Category; Table 2.7: Major Players in the Therapeutics Segment, 2006-07; Table 2.8: Branded Biodrugs in India; Table 2.9: Therapeutics-Commercialised Technology; Table 2.10: Some Examples of Lifestyle Diseases; Table 6.1: Top ten players in Indian Biopharma Sector, 2006-07; Table 7.1: Some Biopiracy Patents Based on Indigeneous Knowledge of India; Table 9.1: Big R&D Spenders in India
List of Charts: Chart 1.1: Indian Biotech Industry; Chart 1.2: Segment Contribution (%) in biotech industry, 2006-07; Chart 1.3: Segmentwise Biotech Export Market share, 2006-07; Chart 1.4: Segmentwise Biotech Domestic Market share, 2006-07; Chart 1.5: Biopharma Sales in India; Chart 1.6: Biopharma- Share of Exports and Domestic Sales, 2006-07; Chart 1.7: Segmentwise Biopharma Sales Contribution, 2005-06; Chart 1.8: Segmentwise Biopharma Sales Contribution, 2006-07; Chart 1.9: % Share of Biopharma to Biotechnology Domestic Sales, 2006-07; Chart 1.10: % Share of Biopharma to Biotechnology Exports, 2006-07; Chart 2.1: Indian Vaccine Market FY2004- FY2007; Chart 2.2: Segment Wise Contribution in the Animal Vaccine Market; Chart 2.3: Major Players in the Indian Poultry Vaccine Market, 2006-07; Chart 2.4: Indian Diagnostic Market, FY2004-FY2007; Chart 2.5: Indian Therapeutics Market, FY2004-FY2007; Chart 2.6: Highest Growing Segments in Indian Therapeutics Market; Chart 3.1: Global Outsourcing Market, 2006; Chart 11.1: Indian Biopharmaceutical Market Forecast

More India Biopharmaceuticals Reports

Strategic Analysis of Indian Biosimilar Market by Frost & Sullivan
This research deliverable provides deep insights into the Biosimilar market in India. It also includes an overview of the Indian regulatory and R&D process briefing ...

Bringing Biologics to Market in the BRIC Countries by Decision Resources
Pharmaceutical companies are realizing the lucrative opportunities for growth offered by biologics because these high-priced drugs can target growing niche markets, compensate for dwindling pipelines, ...

The 2009-2014 Outlook for Biologics in India by Icon Group International, Inc.
This econometric study covers the latent demand outlook for biologics across the states, union territories and cities of India. Latent demand (in millions of U.S. ...

Directory of Top 60 Biopharmaceutical Manufacturers in INDIA by BioPlan Associates, Inc.
A comprehensive industry review: profiles of the established, and rapidly growing, organizations involved in ...

New Directory: Top 60 Biopharmaceutical Manufacturers in INDIA by BioPlan Associates, Inc.
The first edition of the BioPlan India Biopharmaceutical Index includes the Top 60 Biopharmaceutical Companies in India, with detailed profiles of their business focus, products, ...

See all reports like this >>

More India Reports

D&B Country RiskLine Report: India by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...

D&B Country Report: India by Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...

Country Report India January 2011 by Economist Intelligence Unit
Country Reports analyse political and economic trends in featured countries. They show you exactly how national, regional and global events will affect your business in ...

India: Country Profile by MarketLine
INTRODUCTION This report provides a detailed analysis on India, providing an overview of its political, economic and business environment, represented both textually and in graph and ...

2007 India Industry & Market Outlook report by Barnes Reports
The 2007 India Industry & Market Outlook report is the leading annual publication that describes over 100 major industries in India and 500+ minor industries ...

See all reports like this >>

Indian Biopharmaceuticals

Share this report

Other tasks

Research Assistance

Related Markets

Biopharmaceuticals Reports

Free Alert Me service